Mitomycin intravesical - SitusAlternative Names: I-MMC
Latest Information Update: 26 Apr 2007
At a glance
- Originator Situs Corporation
- Class Antineoplastics; Aziridines; Carbamates; Cytostatic antibiotics; Indoles; Small molecules
- Mechanism of Action DNA synthesis inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Bladder cancer
Most Recent Events
- 08 May 2001 I-MMC is available for licensing
- 08 May 2001 New profile
- 08 May 2001 Phase-III clinical trials for Bladder cancer in USA (Intravesicular)